Primary Site >> Colorectal Cancer

Gene >> ATAD2

Journal: Mol Cancer. 2006 May 18;5:20.
Title: Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
Author: De Angelis, Paula M|Svendsrud, Debbie H|Kravik, Katherine L|Stokke, Trond
PMID: 16709241
Journal: BMC Genomics. 2014 Mar 13;15:190.
Title: Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma.
Author: Castle, John C|Loewer, Martin|Boegel, Sebastian|de Graaf, Jos|Bender, Christian|Tadmor, Arbel D|Boisguerin, Valesca|Bukur, Thomas|Sorn, Patrick|Paret, Claudia|Diken, Mustafa|Kreiter, Sebastian|Tureci, Ozlem|Sahin, Ugur
PMID: 24621249
Journal: Gastroenterol Res Pract. 2015;2015:936564.
Title: ATAD2 Overexpression Identifies Colorectal Cancer Patients with Poor Prognosis and Drives Proliferation of Cancer Cells.
Author: Luo, Yang|Ye, Guang-Yao|Qin, Shao-Lan|Yu, Min-Hao|Mu, Yi-Fei|Zhong, Ming
PMID: 26697062
Journal: Jpn J Clin Oncol. 2016 Mar;46(3):222-7.
Title: ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
Author: Hou, Mingming|Huang, Rui|Song, Yanni|Feng, Di|Jiang, Yang|Liu, Ming
PMID: 26819280
Journal: Neoplasma. 2016;63(6):846-855.
Title: Silencing of ATPase family AAA domain-containing protein 2 inhibits migration and invasion of colorectal cancer cells.
Author: Hong, S|Bi, M|Yan, Z|Sun, D|Ling, L|Zhao, C
PMID: 27565322
Journal: Biochem Cell Biol. 2018 Jun 29.
Title: ATAD2 silencing decreases VEGFA secretion through targeting has-miR-520a to inhibit angiogenesis in colorectal cancer.
Author: Hong, Sen|Chen, Si|Wang, Xu|Sun, Di|Yan, Zhenkun|Tai, Jiandong|Bi, Miaomiao
PMID: 29958090